tradingkey.logo

Trevi Therapeutics Provides Strategic Updates Ahead Of Annual Lifesci Partners Corporate Access Event

ReutersJan 8, 2026 12:57 PM

- Trevi Therapeutics Inc TRVI.O:

  • TREVI THERAPEUTICS PROVIDES STRATEGIC UPDATES AHEAD OF ANNUAL LIFESCI PARTNERS CORPORATE ACCESS EVENT HELD DURING THE J.P. MORGAN HEALTHCARE CONFERENCE

  • TREVI THERAPEUTICS INC - FDA END-OF-PHASE 2 MEETING SCHEDULED FOR Q1 2026

  • TREVI THERAPEUTICS INC - PHASE 2B REFRACTORY CHRONIC COUGH TRIAL TO START IN H1 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI